The ARX gene test for Early Infantile Epileptic Encephalopathy Type 1 (EIEE1) is a specialized genetic examination aimed at detecting mutations in the ARX gene, which are known to cause this severe neurological condition. EIEE1 is characterized by frequent seizures that begin within the first few months of life, accompanied by significant developmental delays and intellectual disability. The condition is part of a group of disorders known as ARX-related epilepsies, which are attributed to various mutations within the ARX gene.
DNA Labs UAE offers this critical diagnostic test for families and individuals at risk of or showing symptoms of EIEE1. By employing advanced genetic sequencing techniques, the test scrutinizes the ARX gene for specific mutations that confirm the diagnosis of EIEE1, thereby enabling early intervention, management strategies, and personalized care plans for affected individuals. The cost of the test is set at 4400 AED, reflecting the specialized nature of the examination and the sophisticated technology employed.
Early diagnosis through the ARX gene test can significantly impact the management of the condition, offering insights into potential treatments and therapies that may improve the quality of life for those affected. DNA Labs UAE provides this test with the utmost care and confidentiality, ensuring that patients and their families receive comprehensive support throughout the diagnostic process.
The PNKP gene plays a crucial role in DNA repair and maintenance, and mutations in this gene are associated with early infantile epileptic encephalopathy type 10 (EIEE10), a severe neurological disorder. This condition is characterized by frequent seizures that begin in infancy, developmental delays, and other potential neurological complications. Identifying mutations in the PNKP gene is essential for diagnosing EIEE10, guiding treatment options, and providing information on the prognosis.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the PNKP gene. The test is a vital tool for healthcare professionals and families seeking answers for infants showing symptoms consistent with EIEE10. By providing a definitive diagnosis, this test can help in the management and treatment planning for affected individuals.
The cost of the PNKP gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, typically through a blood draw or cheek swab, and comprehensive analysis to identify any mutations in the PNKP gene. Results from this test can offer invaluable insights for affected families and contribute to a better understanding of the condition, potentially leading to more effective management and care strategies for those diagnosed with early infantile epileptic encephalopathy type 10.
The PLCB1 gene plays a crucial role in brain development and function. Mutations in this gene have been linked to early infantile epileptic encephalopathy type 12 (EIEE12), a severe neurological disorder. This condition is characterized by early-onset seizures, developmental delay, and sometimes other neurological complications. Genetic testing for mutations in the PLCB1 gene is essential for diagnosing EIEE12, guiding treatment options, and providing genetic counseling for affected families.
At DNA Labs UAE, a specialized genetic test is available for identifying mutations in the PLCB1 gene associated with early infantile epileptic encephalopathy type 12. The test involves analyzing the patient's DNA to detect specific genetic alterations that cause the condition. This precise genetic testing is a crucial step in the diagnosis and management of EIEE12, allowing for tailored treatment plans and support for patients and their families.
The cost of the PLCB1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to identify the genetic underpinnings of EIEE12, providing invaluable information for affected individuals and their healthcare providers. Through this testing, DNA Labs UAE offers hope and direction for families navigating the challenges of early infantile epileptic encephalopathy type 12.
The KCNT1 gene is associated with early infantile epileptic encephalopathy type 14 (EIEE14), a severe form of epilepsy that begins in infancy. This condition is characterized by frequent seizures and significant developmental delays, impacting an individual's quality of life. The KCNT1 gene plays a crucial role in the proper functioning of neurons, and mutations in this gene disrupt the normal electrical activity in the brain, leading to epilepsy.
Genetic testing for mutations in the KCNT1 gene is essential for the accurate diagnosis and management of EIEE14. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the KCNT1 gene. The test is a valuable tool for families seeking answers to their child’s severe epilepsy, providing crucial information that can guide treatment decisions and genetic counseling.
The cost of the KCNT1 gene test at DNA Labs UAE is 4400 AED. This investment can be invaluable for affected families, as it not only helps in confirming the diagnosis but also assists in understanding the risk of passing the condition to future generations. Additionally, knowing the specific genetic mutation can open up opportunities for targeted therapies and interventions, potentially improving the quality of life for those affected by EIEE14.
The TBC1D24 gene is associated with early infantile epileptic encephalopathy type 16 (EIEE16), a severe neurological condition that manifests early in infancy. This condition is characterized by frequent seizures that are resistant to treatment, developmental delay, and sometimes additional neurological symptoms. The TBC1D24 gene plays a crucial role in brain development and function, and mutations in this gene are known to disrupt these processes, leading to the symptoms observed in EIEE16.
To diagnose this condition, genetic testing is essential. DNA Labs UAE offers a specific genetic test targeting the TBC1D24 gene to confirm the presence of mutations that cause early infantile epileptic encephalopathy type 16. This test is crucial for the accurate diagnosis of EIEE16, enabling appropriate management and treatment strategies to be implemented for affected individuals. The cost of the TBC1D24 gene test at DNA Labs UAE is 4400 AED.
This test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the TBC1D24 gene for any mutations. The results can provide valuable information for families regarding prognosis, potential treatment options, and the risk of recurrence in future pregnancies. It is also a step forward in understanding the genetic basis of the condition, contributing to ongoing research and potential future therapies.
The DOCK7 gene is associated with early infantile epileptic encephalopathy type 23 (EIEE23), a severe neurological disorder that typically manifests in the early stages of infancy. This condition is characterized by frequent seizures that are resistant to treatment, along with developmental delays and other potential neurological issues. The DOCK7 gene plays a crucial role in brain development and function, and mutations in this gene can disrupt normal neurological processes, leading to the symptoms observed in EIEE23.
To diagnose this condition accurately, genetic testing for mutations in the DOCK7 gene is essential. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the DOCK7 gene that are associated with early infantile epileptic encephalopathy type 23. This test is a critical tool for clinicians in diagnosing the condition, allowing for a better understanding of the prognosis and informing treatment strategies.
The cost of the DOCK7 gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the subsequent analysis of the DOCK7 gene for any mutations. The results from this test can provide invaluable insights for families and healthcare providers, guiding them towards appropriate care and support for affected individuals.
Overall, the DOCK7 gene test offered by DNA Labs UAE is a specialized diagnostic tool that plays a pivotal role in identifying early infantile epileptic encephalopathy type 23, facilitating early intervention and tailored management plans for patients with this challenging condition.
The "ADCY5 Gene Dyskinesia Familial with Facial Myokymia Genetic Test" is a specialized diagnostic tool designed to identify mutations in the ADCY5 gene, which are linked to a rare genetic disorder. This condition is characterized by dyskinesia—a disorder resulting in involuntary, erratic muscle movements—and facial myokymia, which involves continuous, rapid twitching of the facial muscles. These symptoms can significantly impact the quality of life, making accurate diagnosis crucial for management and treatment planning.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing, ensuring high accuracy and reliability of results. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. By pinpointing the specific genetic alterations in the ADCY5 gene, this test enables healthcare professionals to confirm a diagnosis of ADCY5-related dyskinesia, facilitating tailored treatment approaches and genetic counseling for affected individuals and their families.
The PDE10A gene dyskinesia limb and orofacial infantile-onset genetic test is a specialized diagnostic tool aimed at identifying mutations in the PDE10A gene, which have been associated with early-onset movement disorders affecting the limbs and orofacial regions. This condition is characterized by involuntary muscle contractions leading to abnormal postures and movements, significantly impacting the quality of life from a very young age. The test is particularly relevant for individuals displaying symptoms of dyskinesia without a clear diagnosis, offering insights that can guide treatment and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the PDE10A gene. The cost of the test is 4400 AED, reflecting the intricate processes and advanced technology employed to achieve accurate and reliable results. By identifying the genetic underpinnings of the disorder, this test not only facilitates a better understanding of the individual's condition but also aids in the exploration of potential genetic counseling for families, providing them with valuable information regarding the inheritance patterns and risks for future offspring.
The PCDH11X Gene Dyslexia Genetic Test is a specialized diagnostic tool designed to identify genetic markers associated with dyslexia, specifically focusing on the PCDH11X gene located on the X chromosome. This gene has been implicated in neurological development and is thought to play a crucial role in the development of dyslexia, a common learning disorder characterized by difficulties in reading despite normal intelligence and adequate instruction.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers individuals and families insights into the genetic underpinnings of dyslexia, potentially aiding in early detection and the implementation of targeted educational strategies and interventions. The test involves collecting a DNA sample, typically through a simple and non-invasive saliva or blood sample, which is then analyzed for specific genetic variations in the PCDH11X gene that are linked to dyslexia.
The cost of the PCDH11X Gene Dyslexia Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the comprehensive analysis of the genetic sample, a detailed report of the findings, and, in some cases, a consultation to discuss the results and their implications. By identifying a genetic predisposition to dyslexia, parents, educators, and healthcare providers can work together to support individuals with dyslexia, tailoring learning approaches to their unique needs and helping them to achieve their full academic potential.
The ACTB Gene Dystonia Juvenile-Onset Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ACTB gene that are associated with the early onset of dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. The ACTB gene plays a crucial role in the production of beta-actin, a protein essential for cell structure and integrity, and mutations in this gene can disrupt normal muscle function and lead to dystonia.
This genetic test is particularly important for individuals showing symptoms of dystonia at a young age, as early detection can significantly impact the management and treatment options available. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the ACTB gene that are known to cause juvenile-onset dystonia.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test not only aids in the accurate diagnosis of dystonia but also helps in understanding the genetic predisposition of the condition, enabling families to make informed decisions regarding future family planning. The results from this test can also provide valuable information for personalized treatment plans, improving the quality of life for those affected by this challenging condition.
